These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8709645)
1. Morphologic classification of acute myeloid leukemia: concordance among Eastern Cooperative Oncology Group investigators: a comment. Bennett JM; Cassileth PA; Paietta E; Rowe JM; Wiernik PH Leukemia; 1996 Aug; 10(8):1365. PubMed ID: 8709645 [No Abstract] [Full Text] [Related]
2. [The immunophenotypic and cytogenetic characteristics of the blast cells in subvariants of acute myeloid leukemia]. Isakova LM; Tretiak NN; Khromiak VN; Gordienko AI; Zverkova AS; Vakul'chuk AM Tsitol Genet; 2000; 34(1):48-56. PubMed ID: 10808542 [TBL] [Abstract][Full Text] [Related]
3. [Classification of acute leukemias]. Imbert M; Ricard d'Agay MF; André C; Sultan C Ann Biol Clin (Paris); 1981; 39(4):155-64. PubMed ID: 6946721 [No Abstract] [Full Text] [Related]
4. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties. Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298 [TBL] [Abstract][Full Text] [Related]
5. Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations. Litz CE; Davies S; Brunning RD; Kueck B; Parkin JL; Gajl Peczalska K; Arthur DC Leukemia; 1995 Sep; 9(9):1432-9. PubMed ID: 7658708 [TBL] [Abstract][Full Text] [Related]
6. Realistic pathologic classification of acute myeloid leukemias. Arber DA Am J Clin Pathol; 2001 Apr; 115(4):552-60. PubMed ID: 11293903 [TBL] [Abstract][Full Text] [Related]
8. Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival. Bennett JM; Begg CB Cancer Res; 1981 Nov; 41(11 Pt 2):4833-7. PubMed ID: 6945906 [TBL] [Abstract][Full Text] [Related]
9. [Myelocytic leukemia and its classification]. Maekawa T; Umegae S Nihon Rinsho; 1981 Aug; 39(8):2733-40. PubMed ID: 7038197 [No Abstract] [Full Text] [Related]
11. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. Kozlov I; Beason K; Yu C; Hughson M Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957 [TBL] [Abstract][Full Text] [Related]
12. Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implications. Venditti A; Del Poeta G; Stasi R; Buccisano F; Aronica G; Bruno A; Cox C; Maffei L; Tamburini A; Papa G; Amadori S Blood; 1996 Jan; 87(1):418-20. PubMed ID: 8547674 [No Abstract] [Full Text] [Related]
13. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire]. Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262 [TBL] [Abstract][Full Text] [Related]
14. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia]. Merle-Béral H; Boucheix C Rev Prat; 1996 Jan; 46(1):30-6. PubMed ID: 8596888 [TBL] [Abstract][Full Text] [Related]
15. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells. Suárez L; Vidriales MB; Moreno MJ; López A; García-Laraña J; Pérez-López C; Tormo M; Lavilla E; López-Berges MC; de Santiago M; San Miguel JF; Orfao A; Haematologica; 2005 Jan; 90(1):54-9. PubMed ID: 15642669 [TBL] [Abstract][Full Text] [Related]
16. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis. Klobusicka M; Kusenda J; Babusikova O Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082 [TBL] [Abstract][Full Text] [Related]
17. [Differential diagnostic criteria of blast cells in the peripheral blood in acute myeloid leukemias]. Gaĭdukova SN; Guseva SA; Tishchenko LM Vrach Delo; 1989 Sep; (9):38-41. PubMed ID: 2558447 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia. Bacher U; Kern W; Schoch C; Schnittger S; Hiddemann W; Haferlach T Cancer; 2006 Feb; 106(4):839-47. PubMed ID: 16419072 [TBL] [Abstract][Full Text] [Related]
19. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome. Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939 [TBL] [Abstract][Full Text] [Related]
20. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia. Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF; Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]